Molecular subtypes, body mass index (BMI), and their time-varying prognostic impact in node-positive breast cancer (BC): Pooled analysis from the WSG AM-01 and -02 trials.
O. Gluz
Honoraria - Sanofi
C. Liedtke
Honoraria - Sanofi
R. E. Kates
No relevant relationships to disclose
J. B. Huober
Consultant or Advisory Role - Amgen; Sanofi
Honoraria - Sanofi
S. Mohrmann
No relevant relationships to disclose
A. Hartmann
No relevant relationships to disclose
C. Thomssen
Consultant or Advisory Role - Sanofi
Honoraria - Amgen; Sanofi
V. Moebus
Honoraria - Amgen
Research Funding - Amgen
U. Nitz
Consultant or Advisory Role - Sanofi
Honoraria - Amgen; Sanofi
Research Funding - Amgen; Sanofi
N. Harbeck
Consultant or Advisory Role - Sanofi
Honoraria - Amgen; Sanofi
Research Funding - Sanofi